$12.25
-0.37-2.93%
Últ. Act.: Oct 1, 4:27 PM
$12.22
-0.40-3.17%
Dr Reddy's Laboratories (RDY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.17 | $0.09 | $0.16 | $0.18 |
| Actual | $0.06 | $0.03 | $0.16 | $0.19 |
| Surprise | -64.7% | -67.8% | +1.88% | +5.56% |
| Revenue | ||||
| Estimate | $925.5M | $866.1M | $978.1M | $982.9M |
| Actual | $853.0M | $821.8M | $978.8M | $992.0M |
| Surprise | -7.84% | -5.11% | +0.07% | +0.92% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.16 | $0.15 | $0.06 | $0.11 |
| Revenue | ||||
| Consensus | $980.6M | $1.00B | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | Jul 22, 2026 | $0.06 | $0.17 | -64.7 % |
| Q4 | May 12, 2026 | $0.03 | $0.09 | -67.8 % |
| Q3 | Jan 20, 2026 | $0.16 | $0.16 | 1.88 % |
| Q2 | Oct 24, 2025 | $0.19 | $0.18 | 5.56 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | Jul 22, 2026 | $853.00M | $925.53M | -7.84 % |
| Q4 | May 12, 2026 | $821.82M | $866.12M | -5.11 % |
| Q3 | Jan 20, 2026 | $978.82M | $978.10M | 0.07 % |
| Q2 | Oct 24, 2025 | $992.00M | $982.91M | 0.92 % |